Physician profile
Paul T Lee
NPI 1326042680
$3,737.29
in general payments reported to CMS, 2019-2025
39 companies · $825 in 2025
The $825 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $276 · 2021: $248 · 2022: $428 · 2023: $650 · 2024: $654 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,129.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.18 | 2019-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Glaxosmithkline, LLC. | $403.21 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $310.88 | 2023-2025 | Proclaim, Eterna, Penta |
| Abbvie INC. | $265.67 | 2021-2025 | |
| Astellas Pharma US INC | $239.14 | 2019-2022 | |
| Amgen INC. | $213.43 | 2019-2025 | Krystexxa, Repatha, Repatha |
| Lilly USA, LLC | $204.57 | 2020-2025 | Zepbound, Mounjaro, Emgality |
| Merz North America, INC. | $144.32 | 2019 | |
| Pfizer INC. | $134.62 | 2023-2025 | |
| Novo Nordisk INC | $132.65 | 2019-2025 | Ozempic, Rybelsus, Saxenda |
| Merck Sharp & Dohme LLC | $121.18 | 2020-2025 | Gardasil 9, Capvaxive, Pneumovax 23 |
| Astrazeneca Pharmaceuticals LP | $101.69 | 2019-2025 | Breztri, Airsupra |
| Sanofi-Aventis U.S. LLC | $92.16 | 2024-2025 | |
| Hologic Sales and Service, LLC | $86.10 | 2022-2024 | Aptima, Thinprep 2000 Processor |
| Novartis Pharmaceuticals Corporation | $85.11 | 2019-2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.